Nephroprotective Properties of the Glucose

The main incretins are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Additional to the pancreas, receptors for GLP-1 are widely distributed in various organs, causing positive effects on endothelial function and vascular atherogenesis.

Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1), also known as incretins, are hormones released in the intestine in response to the intake of nutrients, and ...
Nephroprotective Properties of the Glucose

Diabetes mellitus is the leading cause of chronic kidney disease, and about 30-40% of patients with diabetes will develop kidney disease. Incretin hormones have received attention during the past three decades not only as a pharmacotherapy for the treatment of type 2 diabetes, but also for their cardiorenometabolic effects. The main incretins are glucagon-like peptide-1 (GLP-1) and glucose ...
The nephroprotective properties of dual GIP and GLP-1 receptor agonists as a new drug to treat type 2 diabetes are presented and preliminary results suggest that tirzepatide improves kidney outcomes in adults with type 1 diabetes with increased cardiovascular risk. Diabetes mellitus is the leading cause of chronic kidney disease, and about 30-40% of patients with diabetes will develop kidney ...

Nephroprotective Properties of the Glucose
Journal Article Summary The article examines the nephroprotective effects of two incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), particularly focusing on their combined use as receptor agonists in treating type 2 diabetes mellitus (T2DM). This topic is significant because diabetes is a leading cause of chronic kidney disease, with a ...
The main incretins are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) [3]. In patients with type 2 diabetes (T2DM), the incretin effect is diminished or completely lost [4].

Overview of Nephroprotective Properties Of The Glucose Dependent Insulinotropic
Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists. Biomedicines, 10 (10), 2586. https://doi.org/10.3390/biomedicines10102586
Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Tomislav Bulum 1,2 Citation: Bulum, T. roprotective Properties of the Glucose-Dependent Insulinotropic Polypepti Academic Editor: Isha Sharma







